2018-11-02 09:09:18,@CRT_News My cancer-free Mum has been killed by a rare reaction to Taxol and/or Herceptin. I have written a post on‚Ä¶ https://t.co/oexaPsr4e2
2018-11-08 20:41:01,"@ThanksCancer It's Herceptin and Perjeta, so not so bad"
2018-11-03 17:44:37,"@fezziwig2008 I understand your reasoning, though I have not seen anything from either Roche or HALO to support tha‚Ä¶ https://t.co/K3tWSbEFzA"
2018-11-02 20:05:22,"@jq1234t @JacobPlieth ZW25 is for sure bispecific. If it wasn‚Äôt, no way they‚Äôd get that kind of responses in patien‚Ä¶ https://t.co/hzrkFHwvGH"
2018-11-02 01:27:17,"@UppityCancerP Yup. I had Taxotere, Carboplatin and Herceptin and that drug cost was $26,000 per cycle. The Hercept‚Ä¶ https://t.co/6wzsfHMUDo"
2018-11-02 09:09:18,@CRT_News My cancer-free Mum has been killed by a rare reaction to Taxol and/or Herceptin. I have written a post on‚Ä¶ https://t.co/oexaPsr4e2
2018-11-02 09:09:18,@CRT_News My cancer-free Mum has been killed by a rare reaction to Taxol and/or Herceptin. I have written a post on‚Ä¶ https://t.co/oexaPsr4e2
2018-11-02 01:27:17,"@UppityCancerP Yup. I had Taxotere, Carboplatin and Herceptin and that drug cost was $26,000 per cycle. The Hercept‚Ä¶ https://t.co/6wzsfHMUDo"
2018-10-30 23:28:44,RT @lucieodonnell: Generally multi-tasking is BAD ü§Øfor your brain and well-being - but in this case it‚Äôs GOOD ‚úÖ.   üíâIn the leg and the arm‚Ä¶
2018-11-09 01:33:19,@Liz_ORiordan @gerryhanna @BreastDocUK @uk_oncologist @ExOncTc @ASCO I can't seem to get the answer to this out of‚Ä¶ https://t.co/L4RSJL8t6t
2018-11-08 20:41:01,"@ThanksCancer It's Herceptin and Perjeta, so not so bad"
2018-11-08 18:08:47,@susietommo Great news  so what next radiotherapy and or endocrine therapy tamoxifen/Lwtrozol and ..ongoing Herceptin or that's it now
2018-11-08 17:00:24,"How do thought leaders view Herceptin, Cyramza, Keytruda, Opdivo, and chemotherapy in the treatment of gastroesopha‚Ä¶ https://t.co/PYlH8P6fCn"
2018-11-06 10:56:06,"@Aggerscricket @MrsAggers Brilliant to hear that you're finally done with your herceptin treatment, and loving the post-chemo hair Emma!"
2018-11-05 19:37:07,RT @biosimilars101: The rapid uptake of #biosimilars is leading to increasing competition and decreasing #biologic sales in Europe. via @Fi‚Ä¶
2018-11-05 19:29:57,"And don't forget that these $$$ drugs also have their own side effects. Herceptin, for example (used in breast ca) has cardiotoxicity."
2018-11-05 17:34:54,RT @biosimilars101: The rapid uptake of #biosimilars is leading to increasing competition and decreasing #biologic sales in Europe. via @Fi‚Ä¶
2018-11-05 17:10:11,The rapid uptake of #biosimilars is leading to increasing competition and decreasing #biologic sales in Europe. via‚Ä¶ https://t.co/Nf8SDhXIRP
2018-11-05 15:10:01,"3.5 years after being diagnosed with Stage 4 Metastatic Breast Cancer, my mom is still the Steel Magnolia of our sw‚Ä¶ https://t.co/LImTsESl47"
2018-11-05 12:51:49,"Herceptin injection day today, just had my 16th of 18. That finishing line is getting nearer. At least there'll be‚Ä¶ https://t.co/atao9LKTgR"
2018-11-05 11:24:44,"@Aggerscricket @MrsAggers We have been in Mauritius for the last 9 days celebrating the final Herceptin for me, gla‚Ä¶ https://t.co/UwqWs1FZXh"
2018-11-04 23:30:54,RT @Maggie_Roch: This isn't a #humblebrag it's a full on one.  Despite having #radiotherapy and  #herceptin yesterday I hit my highest ever‚Ä¶
2018-11-04 17:20:17,"@Maggie_Roch I had my last Herceptin last week. I actually feel like I‚Äôll miss the treatment, and I‚Äôm very much in‚Ä¶ https://t.co/S6Txcc7OpT"
2018-11-04 10:59:48,"@NoWarning_Sign Hey both.  I'm 8/20 through radiotherapy and although will have herceptin jab once every 3 weeks, I‚Ä¶ https://t.co/CecuFkm2Lq"
2018-11-04 06:19:59,"RT @BreastCancerSum: #Breastcancer #Treatment #Development #advance #research #clinical Trials 
clinical trials showed the benefit of hormo‚Ä¶"
2018-11-04 00:36:05,Nov. 2016 (the big pic)‚Äîright in the midst of treatment for initial dx 2017 (top left) 1 yr. later getting last Her‚Ä¶ https://t.co/H0aS7h2uS0
2018-11-03 20:52:11,RT @Maggie_Roch: This isn't a #humblebrag it's a full on one.  Despite having #radiotherapy and  #herceptin yesterday I hit my highest ever‚Ä¶
2018-11-03 20:49:39,This isn't a #humblebrag it's a full on one.  Despite having #radiotherapy and  #herceptin yesterday I hit my highe‚Ä¶ https://t.co/wfYVHF9WJO
2018-11-03 17:44:37,"@fezziwig2008 I understand your reasoning, though I have not seen anything from either Roche or HALO to support tha‚Ä¶ https://t.co/K3tWSbEFzA"
2018-11-03 03:21:43,"Research is great, but It is hard being a patient in the middle of constantly changing standards. I'm glad I stuck‚Ä¶ https://t.co/ba1xfZvql2"
2018-11-02 20:05:22,"@jq1234t @JacobPlieth ZW25 is for sure bispecific. If it wasn‚Äôt, no way they‚Äôd get that kind of responses in patien‚Ä¶ https://t.co/hzrkFHwvGH"
2018-11-02 09:32:29,"@carriekelly @Insurancewith ¬£3000 eek!  I'm due to finish RT this month and Herceptin in May, then apart from 5 yea‚Ä¶ https://t.co/4nYovQneOB"
2018-11-02 09:09:18,@CRT_News My cancer-free Mum has been killed by a rare reaction to Taxol and/or Herceptin. I have written a post on‚Ä¶ https://t.co/oexaPsr4e2
2018-11-02 01:29:29,"@askjillian God bless you.  I went through the same thing two years ago.  Stage 1, but no spreading to nodes.  Stil‚Ä¶ https://t.co/rRVlr93WKo"
2018-11-02 01:27:17,"@UppityCancerP Yup. I had Taxotere, Carboplatin and Herceptin and that drug cost was $26,000 per cycle. The Hercept‚Ä¶ https://t.co/6wzsfHMUDo"
2018-11-02 00:45:04,"RT @UCLAHealth: #Breastcancer survivor credits Dr. Dennis Slamon, a professor of medicine and director of the @UCLAJCCC‚Äôs translational res‚Ä¶"
2018-11-01 10:01:56,"#Breastcancer #Treatment #Development #advance #research #clinical Trials 
clinical trials showed the benefit of ho‚Ä¶ https://t.co/dN36x9ytr9"
2018-10-31 18:36:51,"@UptownMonk1 Too fucking right. We're boob brothers - HER2 and ER+ve. üëç Awaiting MRI, may have surgery first or may‚Ä¶ https://t.co/hrWScZ5S7k"
2018-10-30 23:28:44,RT @lucieodonnell: Generally multi-tasking is BAD ü§Øfor your brain and well-being - but in this case it‚Äôs GOOD ‚úÖ.   üíâIn the leg and the arm‚Ä¶
2018-10-30 23:17:59,"RT @FierceBiotech: Under their last deal, Roche developed the cancer meds Herceptin and Rituxan. It has an undisclosed candidate in phase 1‚Ä¶"
2018-10-30 21:01:01,"#Breastcancer survivor credits Dr. Dennis Slamon, a professor of medicine and director of the @UCLAJCCC‚Äôs translati‚Ä¶ https://t.co/LYIhkZx8tc"
2018-11-09 01:33:19,@Liz_ORiordan @gerryhanna @BreastDocUK @uk_oncologist @ExOncTc @ASCO I can't seem to get the answer to this out of‚Ä¶ https://t.co/L4RSJL8t6t
2018-11-08 18:08:47,@susietommo Great news  so what next radiotherapy and or endocrine therapy tamoxifen/Lwtrozol and ..ongoing Herceptin or that's it now
2018-11-06 17:13:36,RT @CancerMedMDA: Trastuzumab (Herceptin) linked to heart issues in breast cancer patients: Cardiac monitoring should be a priority for hig‚Ä¶
2018-11-06 14:38:36,RT @CancerMedMDA: Trastuzumab (Herceptin) linked to heart issues in breast cancer patients: Cardiac monitoring should be a priority for hig‚Ä¶
2018-11-06 13:55:56,Trastuzumab (Herceptin) linked to heart issues in breast cancer patients: Cardiac monitoring should be a priority f‚Ä¶ https://t.co/NrUZm9VrMm
2018-11-06 13:39:20,"I didn‚Äôt even have to read this to know that the ‚Äúshit plan‚Äù loss was the harm done.

One round of BC (T1N0M0) knoc‚Ä¶ https://t.co/DMeFNKVCno"
2018-11-03 17:44:37,"@fezziwig2008 I understand your reasoning, though I have not seen anything from either Roche or HALO to support tha‚Ä¶ https://t.co/K3tWSbEFzA"
2018-11-02 09:35:10,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-02 09:09:18,@CRT_News My cancer-free Mum has been killed by a rare reaction to Taxol and/or Herceptin. I have written a post on‚Ä¶ https://t.co/oexaPsr4e2
2018-11-02 07:36:45,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-02 01:57:01,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-01 22:41:44,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-01 17:48:59,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-01 17:14:39,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-01 15:09:28,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-01 14:18:42,"RT @UppityCancerP: With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is the que‚Ä¶"
2018-11-01 13:25:46,"With Herceptin &amp; Perjeta, my every 3 week treatments now charged at over $30,000. WTF? Your money or you life is th‚Ä¶ https://t.co/6qcEbJ6st2"
2018-10-31 18:36:51,"@UptownMonk1 Too fucking right. We're boob brothers - HER2 and ER+ve. üëç Awaiting MRI, may have surgery first or may‚Ä¶ https://t.co/hrWScZ5S7k"
2018-11-10 00:04:41,Dad back in the hospital as he is a fall risk and increasingly confused. Sudden onset weakness/confusion as a side‚Ä¶ https://t.co/kH3XPzk771
2018-11-07 21:33:17,@Fact_eur I have hope. Zytiga and Jevtana together. Surely I‚Äôll get some mileage out of that!
2018-11-05 14:56:31,@ThanksCancer @SU2C But different chemo this time and I‚Äôm taking an additional hormone treatment. (abiraterone/Zyti‚Ä¶ https://t.co/TbuSatjiMM
2018-11-01 14:46:03,"Director Dennies Varughese and associate Cassandra Simmons scored a nice WIN that is covered in this article, ‚ÄúNJ J‚Ä¶ https://t.co/IO0oO5thpL"
2018-10-31 16:30:59,A slight change of plans: my Urologist agrees with me that it‚Äôs probably Zytiga causing the creatinine jump and wan‚Ä¶ https://t.co/AjO99ayw5a
2018-10-31 16:14:51,"Director Dennies Varughese and associate Cassandra Simmons were mentioned as representing Wockhardt in the article,‚Ä¶ https://t.co/tuq0abKVn0"
2018-11-08 14:04:26,"Do you love Oktoberfest? So do we! If celebrating cultural diversity is important to you in your next career move,‚Ä¶ https://t.co/TQyASbJO4d"
2018-11-07 20:12:44,"Here is the summary of my AI talk I gave today - https://t.co/pWjR2ryiQw. Also, recently hosted and took part in an‚Ä¶ https://t.co/hANMneBson"
2018-11-02 01:27:17,"@UppityCancerP Yup. I had Taxotere, Carboplatin and Herceptin and that drug cost was $26,000 per cycle. The Hercept‚Ä¶ https://t.co/6wzsfHMUDo"
2018-11-02 00:45:04,"RT @UCLAHealth: #Breastcancer survivor credits Dr. Dennis Slamon, a professor of medicine and director of the @UCLAJCCC‚Äôs translational res‚Ä¶"
2018-10-30 23:17:59,"RT @FierceBiotech: Under their last deal, Roche developed the cancer meds Herceptin and Rituxan. It has an undisclosed candidate in phase 1‚Ä¶"
2018-10-30 21:01:01,"#Breastcancer survivor credits Dr. Dennis Slamon, a professor of medicine and director of the @UCLAJCCC‚Äôs translati‚Ä¶ https://t.co/LYIhkZx8tc"
2018-11-09 22:15:04,#Genentech Settles #Rituximab Patent Dispute with #Celltrion and Teva via @Big_Molecule https://t.co/0YZ4cNV5gL https://t.co/XrXHWGE8WX
2018-11-09 21:48:06,"Practice-directing implications for grade 3a FL.

ASH Paper: Outcomes of Follicular Lymphoma Patients Treated with‚Ä¶ https://t.co/18jfsc1IDw"
2018-11-09 18:54:15,RT @NuwavePharm: Remember to check Immunoglobulin levels before and after rituximab administration--low levels are not uncommon and are tie‚Ä¶
2018-11-09 17:59:05,Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR: Chronicactive antibodymediated rejection cA‚Ä¶ https://t.co/u7u3WUVQhJ
2018-11-09 16:59:37,RT @patent: Patent News: Genentech Settles Rituximab Patent Dispute with Celltrion and Teva https://t.co/qpMdBQWaHn #patents
2018-11-09 15:17:16,RT @JourNephrology: #Hypogammaglobulinemia screening needed for patients receiving #rituximab. Read and Submit related articles at: Journal‚Ä¶
2018-11-09 15:16:29,RT @Jmarksloan: Why can‚Äôt we use daratumumab for serious benign antibody mediated diseases?  Eg patient w acquired hemophilia A currently g‚Ä¶
2018-11-09 14:44:12,Remember to check Immunoglobulin levels before and after rituximab administration--low levels are not uncommon and‚Ä¶ https://t.co/tU6PTTxSx2
2018-11-09 13:41:42,Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36‚Ä¶ https://t.co/t62WfdWicc
2018-11-09 12:19:44,RT @JourNephrology: #Hypogammaglobulinemia screening needed for patients receiving #rituximab. Read and Submit related articles at: Journal‚Ä¶
2018-11-09 12:17:28,RT @dave6408: CD47 Blockade and Rituximab in Ph I in R/R NHL (n=22):  complete and sustained responses in DLBCL and FL https://t.co/kuDUK31‚Ä¶
2018-11-09 09:58:11,#Hypogammaglobulinemia screening needed for patients receiving #rituximab. Read and Submit related articles at: Jou‚Ä¶ https://t.co/KSCjhCMNW7
2018-11-09 07:00:23,"Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia | All‚Ä¶ https://t.co/Q2lpbE9KNL"
2018-11-09 06:03:03,RT @JAMANetworkOpen: Increased immunological screening required before and after rituximab to identify higher risks for infectious complica‚Ä¶
2018-11-09 06:00:00,RT @JAMANetworkOpen: Increased immunological screening required before and after rituximab to identify higher risks for infectious complica‚Ä¶
2018-11-09 05:48:00,RT @RheumJnl: Use and effectiveness of #rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the‚Ä¶
2018-11-09 05:45:58,RT @RheumJnl: Use and effectiveness of #rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the‚Ä¶
2018-11-09 03:38:13,Patent News: Genentech Settles Rituximab Patent Dispute with Celltrion and Teva https://t.co/qpMdBQWaHn #patents
2018-11-08 17:01:43,@Jmarksloan @connors_md @brendanweiss @MyelomaRnD What would be the cost difference relative to Rituximab and would Insurance cover Dara?
2018-11-08 16:53:25,RT @sheik2411: Sandoz Abandons Its US Biosimilar Rituximab Plans https://t.co/VBNxBh8tFj via @biosimcenter  This was sad to see and we expe‚Ä¶
2018-11-08 15:52:52,"@guiperini @gerardoperilla According to @SIOGorg Guidelines for older adults with #DLBCL, when possible, give a reg‚Ä¶ https://t.co/31jUEFp4aY"
2018-11-08 15:52:14,Combinatory treatment with 5F9 and rituximab (anti-CD20) resulted in substantial anti-lymphoma activity w complete‚Ä¶ https://t.co/OgZhWElACN
2018-11-08 11:40:05,Sandox axes #biosimilar rituximab program emphasizing time sensitivity of biosimilar launches &amp; fear of rapid price‚Ä¶ https://t.co/8A73lgYKnw
2018-11-08 10:00:25,Therapy combines an experimental antibody [Hu5F9-G4] developed by researchers at @StanfordMed &amp; a commercially avai‚Ä¶ https://t.co/agF98iC08x
2018-11-08 07:34:31,"""Twelve of 13 patients were initially treated with 2 √ó 1 g RTX infusions
2 weeks apart, reflecting the regimen used‚Ä¶ https://t.co/WACUaS9qz3"
2018-11-08 00:21:58,Phase III comparative results on rituximab and its biosimilar CT-P10 in low-tumor burden FL. Read more here‚Ä¶ https://t.co/bsXffJSpZQ
2018-11-07 22:04:25,RT @josh_whitehill: Genentech Settles #Rituximab #Biosimilar Patent Dispute with Celltrion and Teva https://t.co/BG8Ik7WqYR
2018-11-07 21:32:37,RT @josh_whitehill: Genentech Settles #Rituximab #Biosimilar Patent Dispute with Celltrion and Teva https://t.co/BG8Ik7WqYR
2018-11-07 21:26:42,Genentech Settles #Rituximab #Biosimilar Patent Dispute with Celltrion and Teva https://t.co/BG8Ik7WqYR
2018-11-07 21:01:11,#Genentech Settles #Rituximab Patent Dispute with #Celltrion and Teva https://t.co/M2iyjP0DDy
2018-11-07 17:44:31,RT @sheik2411: Sandoz Abandons Its US Biosimilar Rituximab Plans https://t.co/VBNxBh8tFj via @biosimcenter  This was sad to see and we expe‚Ä¶
2018-11-07 17:15:54,Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamus‚Ä¶ https://t.co/SXAxMAPYRJ
2018-11-07 14:49:47,RT @sheik2411: Sandoz Abandons Its US Biosimilar Rituximab Plans https://t.co/VBNxBh8tFj via @biosimcenter  This was sad to see and we expe‚Ä¶
2018-11-07 13:11:17,RT @sheik2411: Sandoz Abandons Its US Biosimilar Rituximab Plans https://t.co/VBNxBh8tFj via @biosimcenter  This was sad to see and we expe‚Ä¶
2018-11-07 13:03:36,Sandoz Abandons Its US Biosimilar Rituximab Plans https://t.co/VBNxBh8tFj via @biosimcenter  This was sad to see an‚Ä¶ https://t.co/mbhm2bMryB
2018-11-07 04:29:56,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-07 04:12:24,"RT @syed_abutalibmd: Paper: Safety and Efficacy of Venetoclax Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide Chemoimmunothe‚Ä¶"
2018-11-07 00:41:56,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-07 00:22:07,"RT @WinshipAtEmory: In this @OncLive video, Winship hematologist Jonathon Cohen, MD (@jonathonbcohen) discussed findings from a study of po‚Ä¶"
2018-11-06 23:59:29,"Paper: Safety and Efficacy of Venetoclax Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide Chemoimmuno‚Ä¶ https://t.co/l9KRgcQniv"
2018-11-06 23:58:43,"Paper: Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma - Inte‚Ä¶ https://t.co/sQypWURR57"
2018-11-06 20:15:36,"RT @WinshipAtEmory: In this @OncLive video, Winship hematologist Jonathon Cohen, MD (@jonathonbcohen) discussed findings from a study of po‚Ä¶"
2018-11-06 16:59:13,"Association of Immunoglobulin, Infection, and Mortality With #Rituximab and Hypogammaglobulinemia 
#JAMAopen 
https://t.co/2xc2vcyqPV"
2018-11-06 15:18:41,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 15:05:15,"In this @OncLive video, Winship hematologist Jonathon Cohen, MD (@jonathonbcohen) discussed findings from a study o‚Ä¶ https://t.co/JiJIEvpdAl"
2018-11-06 14:51:54,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 13:53:54,Sandoz Decides Not To Pursue US Biosimilar Rituximab; Will Focus On Robust Biosimilar Portfolio For Unmet Access An‚Ä¶ https://t.co/rQ4qoYKWKc
2018-11-06 13:41:06,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 13:35:12,"$NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in‚Ä¶ https://t.co/skfSnuGsuw"
2018-11-06 11:14:47,Efficacy of rituximab as a single-agent therapy for the treatment of Granulomatous and Lymphocytic Interstitial Lun‚Ä¶ https://t.co/lkK0nLG4Qy
2018-11-06 09:05:01,"Over-the-counter cough and cold medicines won't ease symptoms for children under age 6, and other #healthnews‚Ä¶ https://t.co/gAlJsuZKre"
2018-11-06 08:44:04,RT @EurekaMag: Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder https://t.co/34Hvkd‚Ä¶
2018-11-06 08:44:04,RT @EurekaMag: Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder https://t.co/34Hvkd‚Ä¶
2018-11-06 08:32:32,RT @EurekaMag: Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder https://t.co/34Hvkd‚Ä¶
2018-11-06 08:32:07,Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder‚Ä¶ https://t.co/Dp1Yilpyyk
2018-11-06 05:30:11,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-06 04:58:21,"RT @eliowa: Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia https://t.co/TdPi‚Ä¶"
2018-11-06 02:31:20,"RT @ZacharyBrennan: missed this on the rituximab biosimilar decision with Sandoz saying it believes ""the patient and marketplace needs in t‚Ä¶"
2018-11-06 01:02:25,"RT @eliowa: Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia https://t.co/TdPi‚Ä¶"
2018-11-06 01:00:00,"When it comes time to set the clocks back an hour for daylight saving time, hospitals opt for paper records during‚Ä¶ https://t.co/WaBywm4exW"
2018-11-06 00:08:27,"RT @Brandon_Beaber: CRION (chronic relapsing inflammatory optic neuropathy) related to anti-MOG antibodies.  I now have 2-3 cases of this,‚Ä¶"
2018-11-05 23:51:48,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 23:49:06,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 23:40:02,CRION (chronic relapsing inflammatory optic neuropathy) related to anti-MOG antibodies.  I now have 2-3 cases of th‚Ä¶ https://t.co/qznkwFZayN
2018-11-05 23:06:24,"Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia https://t.co/TdPii7VLHI"
2018-11-05 22:52:37,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 21:45:19,RT @dave6408: CD47 Blockade and Rituximab in Ph I in R/R NHL (n=22):  complete and sustained responses in DLBCL and FL https://t.co/kuDUK31‚Ä¶
2018-11-05 21:00:00,"RT @ZacharyBrennan: missed this on the rituximab biosimilar decision with Sandoz saying it believes ""the patient and marketplace needs in t‚Ä¶"
2018-11-05 20:57:06,"missed this on the rituximab biosimilar decision with Sandoz saying it believes ""the patient and marketplace needs‚Ä¶ https://t.co/vJlvZqYo1e"
2018-11-05 20:30:00,#ICYMI: Long-term data from the phase III HELIOS trial indicates ibrutinib plus bendamustine and rituximab improve‚Ä¶ https://t.co/xZlDVaiTbm
2018-11-05 18:06:19,@oomchaqueen Oh wow: hope DEXA went ok and all the best with Rituximab tomorrow. I'm going ahead with lumbar punctu‚Ä¶ https://t.co/drB8oWuipn
2018-11-05 17:46:34,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 16:44:11,https://t.co/HI8reENaxy Sandoz Decides Not To Pursue UsSBiosimilar Rituximab; Will Focus On Robust Biosimilar Portfolio For Unmet Access...
2018-11-05 14:19:58,"On Friday, Sandoz announced that it will no longer seek FDA approval of its biosimilar rituximab, though the produc‚Ä¶ https://t.co/auPAqwkL4Q"
2018-11-05 13:40:15,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 13:29:57,"Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previ‚Ä¶ https://t.co/d78PPzPj9L"
2018-11-05 13:25:34,"RT @TargetedOnc: Dr. Cohen from @WinshipAtEmory discussed findings from a study of polatuzumab vedotin, with bendamustine and rituximab in‚Ä¶"
2018-11-05 13:10:46,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 12:38:48,Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access an‚Ä¶ https://t.co/1DHiWsloAn
2018-11-05 11:07:56,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 10:38:03,RT @CDRLifeSciences: Nordic Nanovector announces first patient dosed in Archer-1 trial of Betalutin plus Rituximab in Follicular Lymphoma #‚Ä¶
2018-11-05 09:15:09,"Novartis abandons effort for U.S. approval of biosimilar rituximab

The decision comes after the U.S. Food and Drug‚Ä¶ https://t.co/OMjeuUGWlp"
2018-11-05 08:51:42,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 06:59:20,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 06:14:35,New: Rituximab and the risk of infections in rheumatoid arthritis https://t.co/5VqN8Dhdzo via @medivizor #Rheum
2018-11-05 06:09:53,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 06:07:36,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 05:49:44,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 05:37:01,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 05:20:58,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 04:46:09,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 04:27:29,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 04:26:51,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 03:56:01,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 02:58:28,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 02:45:25,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 02:41:27,"RT @OneOncology: A recent clinical trial by top researchers, including our own Tennessee Oncology, shows great strides in #cancer #research‚Ä¶"
2018-11-05 02:16:10,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 02:04:49,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:45:54,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:41:01,RT @dave6408: CD47 Blockade and Rituximab in Ph I in R/R NHL (n=22):  complete and sustained responses in DLBCL and FL https://t.co/kuDUK31‚Ä¶
2018-11-05 01:36:58,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:20:02,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:15:51,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:12:53,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:10:09,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:09:00,"Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/OcihqlEdFm

Editor‚Ä¶ https://t.co/LJg2SCvbyK"
2018-11-05 01:07:29,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:03:58,"Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/Ta9EsXT3Nq

Editor‚Ä¶ https://t.co/kLalAotYtM"
2018-11-05 01:02:50,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:01:54,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 01:00:31,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 00:53:52,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 00:52:31,RT @dave6408: CD47 Blockade and Rituximab in Ph I in R/R NHL (n=22):  complete and sustained responses in DLBCL and FL https://t.co/kuDUK31‚Ä¶
2018-11-05 00:51:24,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 00:50:08,"RT @NEJM: Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editorial: Macrophag‚Ä¶"
2018-11-05 00:50:06,"Original Article: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma https://t.co/ZCOI8eB8fM

Editor‚Ä¶ https://t.co/e2CiD4zMqw"
2018-11-05 00:44:46,CD47 Blockade and Rituximab in Ph I in R/R NHL (n=22):  complete and sustained responses in DLBCL and FL https://t.co/kuDUK31TWR
2018-11-04 20:25:33,RT @JAMADerm: This cohort study evaluates outcomes of rituximab treatment in patients with different clinical subtypes of cutaneous #lupus‚Ä¶
2018-11-04 19:12:11,RT @JAMANetworkOpen: Increased immunological screening required before and after rituximab to identify higher risks for infectious complica‚Ä¶
2018-11-04 17:54:22,Novartis International AG: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimil https://t.co/vaJLbKzMY0
2018-11-04 17:24:07,@zalphaprime @rmbctious @Zombie_Cartman @Mwforhr @TakeThatEpi @costello864 @Zessshy @RJDownard @Cern_lXXl‚Ä¶ https://t.co/aVt2C1ECIH
2018-11-04 17:00:01,Increased immunological screening required before and after rituximab to identify higher risks for infectious compl‚Ä¶ https://t.co/1lDwRIN1P1
2018-11-04 14:21:09,RT @Biotech2050: 1594¬†Seven Year Follow up and Comparison of Dosing Strategies from the Pivotal Phase II Clinical Trial of #Lenalidomide Pl‚Ä¶
2018-11-04 13:57:42,Immunotherapy is not *that* new.  Rituximab and other monoclonal antibodies (mAbs) have been in trials since the ea‚Ä¶ https://t.co/DkMYcJtPEu
2018-11-04 13:50:19,"CD47 Blockade and Rituximab in Non-Hodgkin's Lymphoma. https://t.co/qipayFi7iG  #lymsm

Intriguing and potentially‚Ä¶ https://t.co/U9UblKFRNu"
2018-11-04 09:58:15,RT @WorldHealthNews: Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory appr‚Ä¶
2018-11-04 07:48:32,RT @BiosimilarsBio: $NVS Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access a‚Ä¶
2018-11-04 07:00:11,"Dr. Cohen from @WinshipAtEmory discussed findings from a study of polatuzumab vedotin, with bendamustine and rituxi‚Ä¶ https://t.co/DSu3IJCr5g"
2018-11-04 03:37:41,Novartis International AG: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimil https://t.co/vaJLbKzMY0
2018-11-04 03:05:15,RT @WorldHealthNews: Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory appr‚Ä¶
2018-11-04 01:11:18,RT @semodough: $ATRA: They are presenting 7 abstracts at ASH and highlights will include a CNS subset analysis in EBV+ PTLD (important -- h‚Ä¶
2018-11-03 23:12:20,RT @chriswincup: What an honour to be able to talk about our work on Rituximab antibodies in lupus at #ACR18 Thanks to @Jury_Lab @Mauri_gro‚Ä¶
2018-11-03 18:35:11,$ATRA: They are presenting 7 abstracts at ASH and highlights will include a CNS subset analysis in EBV+ PTLD (impor‚Ä¶ https://t.co/3QHDyVuoeu
2018-11-03 16:14:03,New Studies Highlight Performance of Vectra¬Æ Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofac‚Ä¶ https://t.co/SGZLjQMPmK
2018-11-03 14:00:01,This cohort study evaluates outcomes of rituximab treatment in patients with different clinical subtypes of cutaneo‚Ä¶ https://t.co/Wncft3rHoE
2018-11-03 13:12:58,Novartis International AG: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimil https://t.co/vaJLbKzMY0
2018-11-03 08:27:20,RT @odibro: $NVS Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and susta‚Ä¶
2018-11-03 08:17:49,1594¬†Seven Year Follow up and Comparison of Dosing Strategies from the Pivotal Phase II Clinical Trial of‚Ä¶ https://t.co/RsgS5EMzTW
2018-11-03 07:48:18,https://t.co/83Fjw4c6Et Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portf‚Ä¶ https://t.co/zmm8mP2APb
2018-11-03 07:31:04,RT @ClinicalPhase: IbrutinibBR Combo Improves Survival in CLL: Longterm data from the phase III HELIOS trial indicates ibrutinib plus benda‚Ä¶
2018-11-03 07:25:19,Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory a‚Ä¶ https://t.co/4r2CJ7rW91
2018-11-03 06:56:53,RT @WikiScene_Infos: Novartis International AG - Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar port‚Ä¶
2018-11-03 06:45:11,Novartis: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet‚Ä¶ https://t.co/jOUdlb70LO
2018-11-03 04:17:17,Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access an‚Ä¶ https://t.co/4PqbRYcodB
2018-11-03 01:48:03,RT @AntibodyNews: CD47 Blockade by Hu5F9G4 and Rituximab in NonHodgkin's Lymphoma.: The Hu5F9G4 hereafter 5F9 antibody is a macrophage immu‚Ä¶
2018-11-03 01:47:02,$NVS Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet acce‚Ä¶ https://t.co/XpG7W8Jndk
2018-11-03 01:37:02,"@EBRheum Definitely something to look out for. We had a decent number of patients on the trial, and other then infu‚Ä¶ https://t.co/qZICtaABFO"
2018-11-03 00:09:01,Novartis International AG: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimil https://t.co/vaJLbKzMY0
2018-11-02 23:19:25,ASH Paper: Comparison of Efficacy and Safety of Biosimilar CT-P10 to Rituximab in Patients with Previously Untreate‚Ä¶ https://t.co/t5UbETVC66
2018-11-02 23:07:57,"RT @FayCortez: Novartis throws in the towel on generic rituximab, after launching in the EU, Japan and Australia. What's that about high dr‚Ä¶"
2018-11-02 22:49:12,RT @RoschewskiMD: This study open here @NCICCR_Lymphoma currently. Important target and good early results.  Plans to better understand whi‚Ä¶
2018-11-02 22:44:24,"RT @FayCortez: Novartis throws in the towel on generic rituximab, after launching in the EU, Japan and Australia. What's that about high dr‚Ä¶"
2018-11-02 22:25:32,"Novartis throws in the towel on generic rituximab, after launching in the EU, Japan and Australia. What's that abou‚Ä¶ https://t.co/PaR72Z3fRr"
2018-11-02 22:23:48,Novartis AG: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for un‚Ä¶ https://t.co/zmArAlihEw
2018-11-02 22:17:08,"Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia | All‚Ä¶ https://t.co/jDHKPNrZgA"
2018-11-02 22:10:08,Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and https://t.co/pgNAazBLjz
2018-11-02 22:09:22,Novartis International AG: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimil https://t.co/eyKZ1OILme
2018-11-02 22:09:00,$NVS Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet acce‚Ä¶ https://t.co/FPkdQXIZoW
2018-11-02 22:05:01,Novartis International AG - Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar p‚Ä¶ https://t.co/v7RKRkyTw7
2018-11-02 22:03:58,RT @GNWLive: Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet $NOVN https://t.co/p‚Ä¶
2018-11-02 22:02:21,Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet $NOVN https://t.co/pHslOOXC2m
2018-11-02 20:09:45,RT @RoschewskiMD: This study open here @NCICCR_Lymphoma currently. Important target and good early results.  Plans to better understand whi‚Ä¶
2018-11-02 20:08:57,RT @RoschewskiMD: This study open here @NCICCR_Lymphoma currently. Important target and good early results.  Plans to better understand whi‚Ä¶
2018-11-02 20:00:00,RT @RoschewskiMD: This study open here @NCICCR_Lymphoma currently. Important target and good early results.  Plans to better understand whi‚Ä¶
2018-11-02 14:06:26,@AndyBiotech Not surprising given the ton of biosimilar applications I prepared in my last job.  At one point I thi‚Ä¶ https://t.co/Jxioi1d8sW
2018-11-02 13:45:22,This study open here @NCICCR_Lymphoma currently. Important target and good early results.  Plans to better understa‚Ä¶ https://t.co/mbTRHsnB4n
2018-11-02 13:40:29,"RT @Rfonsi1: . Very interesting data. ORR 50% RR NHL.  CD47 is a ""do not eat me"" signal that allows tumors to survive.  We and others have‚Ä¶"
2018-11-02 13:28:09,"RT @semodough: $CLDX Ph. I/II varli+nivo combo data at SITC
 $CLSD SAPPHIRE data readout
$IOVA Update from Ph. II cohort 2
 $NBIX Results f‚Ä¶"
2018-11-02 12:00:59,"RT @semodough: $CLDX Ph. I/II varli+nivo combo data at SITC
 $CLSD SAPPHIRE data readout
$IOVA Update from Ph. II cohort 2
 $NBIX Results f‚Ä¶"
2018-11-02 10:05:12,Nordic Nanovector announces first patient dosed in Archer-1 trial of Betalutin plus Rituximab in Follicular Lymphom‚Ä¶ https://t.co/dNuMskx1EC
2018-11-02 09:08:03,RT @magicbulletbio: Nordic Nanovector announces first patient dosed in ARCHER-1 phase 1b clinical study combining Rituximab and Betalutin i‚Ä¶
2018-11-02 07:42:36,"ARCHER-1 study came as a direct result of preclinical findings presented at #ASH16.
""If the same effect is confirme‚Ä¶ https://t.co/CTqnXRujBn"
2018-11-02 07:41:09,Nordic Nanovector announces first patient dosed in ARCHER-1 phase 1b clinical study combining Rituximab and Betalut‚Ä¶ https://t.co/H5I5fUfhmd
2018-11-02 07:22:05,RT @arthritis_bio: B cell depletion therapy dampens CD8 T cell response in ANCAassociated vasculitis.: To compare the effects of rituximab‚Ä¶
2018-11-02 07:09:03,RT @RitaDege: Nordic Nanovector Announces First Patient Dosed in Archer-1 Trial of Betalutin¬Æ plus Rituximab in Follicular Lymphoma. https:‚Ä¶
2018-11-02 06:58:43,RT @RitaDege: Nordic Nanovector Announces First Patient Dosed in Archer-1 Trial of Betalutin¬Æ plus Rituximab in Follicular Lymphoma. https:‚Ä¶
2018-11-02 06:10:03,Nordic Nanovector Announces First Patient Dosed in Archer-1 Trial of Betalutin¬Æ plus Rituximab in Follicular Lympho‚Ä¶ https://t.co/UdIutb1Llx
2018-11-02 01:39:24,"$CLDX Ph. I/II varli+nivo combo data at SITC
 $CLSD SAPPHIRE data readout
$IOVA Update from Ph. II cohort 2
 $NBIX‚Ä¶ https://t.co/2JysSr1z8g"
2018-11-01 22:07:41,#CD47 Blockade by #Hu5F9-G4 and #Rituximab in Non-Hodgkin‚Äôs #Lymphoma | #NEJM https://t.co/e3sr4IX3qv
2018-11-01 21:35:06,"A recent clinical trial by top researchers, including our own Tennessee Oncology, shows great strides in #cancer‚Ä¶ https://t.co/BC43z0XQ57"
2018-11-01 20:43:10,RT @UCCancerCenter: Check it out! Great video summarizing data from multicenter Ph1b study led by Dr. Soni Smith showing promising activity‚Ä¶
2018-11-01 20:28:03,"Promising tests at Stanford University of Hu5F9-G4, that blocks protein #CD47, and #Rituximab against types of non-‚Ä¶ https://t.co/MuES6IIDxG"
2018-11-01 19:46:51,CD47 Blockade by Hu5F9G4 and Rituximab in NonHodgkin's Lymphoma.: The Hu5F9G4 hereafter 5F9 antibody is a macrophag‚Ä¶ https://t.co/SbHgJuVFQm
2018-11-01 19:29:06,IbrutinibBR Combo Improves Survival in CLL: Longterm data from the phase III HELIOS trial indicates ibrutinib plus‚Ä¶ https://t.co/fC1DomwwOC
2018-11-01 18:24:33,RT @BCRD_Study: New BCRD research on use and effectiveness of rituximab in children and young people with JIA by @KearsleyFleet published i‚Ä¶
2018-11-01 16:40:58,Audience discussion: mesothelin should be bound by antibody; hence using alternative marker (MPF). Same scenario se‚Ä¶ https://t.co/j91PiPzNsE
2018-11-01 15:00:19,"ICYMI: 4 people have been indicted for allegedly stealing trade secrets related to dornase alfa, rituximab, trastuz‚Ä¶ https://t.co/dmysuZCVeR"
2018-11-01 14:57:07,Check it out! Great video summarizing data from multicenter Ph1b study led by Dr. Soni Smith showing promising acti‚Ä¶ https://t.co/evjECKhSSe
2018-11-01 13:49:59,RT @BCRD_Study: New BCRD research on use and effectiveness of rituximab in children and young people with JIA by @KearsleyFleet published i‚Ä¶
2018-11-01 13:15:17,"CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma [Nov 1, 2018] Advani et al. @NEJM‚Ä¶ https://t.co/mNDcDgbZUi"
2018-11-01 12:40:26,"RT @jasonsknight: What I'm reading this morning üìö In a mouse model of multiple sclerosis, suppressor neutrophils restrain infiltration of B‚Ä¶"
2018-11-01 12:19:46,"CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma | NEJM https://t.co/qlHNoPZqKB
New window of oppo‚Ä¶ https://t.co/aZgx9jYi6o"
2018-11-01 10:49:01,"What I'm reading this morning üìö In a mouse model of multiple sclerosis, suppressor neutrophils restrain infiltratio‚Ä¶ https://t.co/MjcK8cjxiu"
2018-11-01 07:13:56,"@RFDesigngirl i had Rituximab years ago and didnt really flare for year's, i want it again"
2018-11-01 02:35:54,RT @rkridel: Fascinating way to treat lymphoma via macrophage checkpoint blockade: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs‚Ä¶
2018-11-01 02:26:38,RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
2018-11-01 02:25:44,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:24:16,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:22:41,RT @JAMANeuro: Efficacy and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorders https://t.co/AwXDbWB960
2018-11-01 02:20:54,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:20:02,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:20:00,RT @rkridel: Fascinating way to treat lymphoma via macrophage checkpoint blockade: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs‚Ä¶
2018-11-01 02:18:19,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:17:29,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:16:45,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:14:24,"RT @CambridgeNeuro1: No increased risk of malignancy from rituximab, compared to natalizumab and fingolimod from a population of 33,712 pat‚Ä¶"
2018-11-01 02:14:16,"RT @KidneyTreat: Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 02:13:30,"RT @ElimRheumCtr: It appears that far lower doses of Rituximab than what is currently given, albeit at shorter intervals, can deplete B-cel‚Ä¶"
2018-11-01 02:11:40,Potentiating the effects of rituximab on refractory DLBCL  by targeting eat me/ don‚Äôt eat me signals between macrop‚Ä¶ https://t.co/bRKqx5vC4H
2018-11-01 01:53:22,"Rituximab Can Replace Steroid and Reduce the Relapse of Nephrotic Syndrome
https://t.co/gZcXz9rNGl https://t.co/V0VhTXUHZ3"
2018-11-01 01:30:50,"Myeloid immune checkpoints, which regulate macrophage activation against tumors, are the next frontier of cancer im‚Ä¶ https://t.co/DLptF9WUln"
2018-11-01 00:52:56,RT @rkridel: Fascinating way to treat lymphoma via macrophage checkpoint blockade: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs‚Ä¶
2018-11-01 00:18:32,"RT @Rfonsi1: . Very interesting data. ORR 50% RR NHL.  CD47 is a ""do not eat me"" signal that allows tumors to survive.  We and others have‚Ä¶"
2018-11-01 00:10:02,RT @rkridel: Fascinating way to treat lymphoma via macrophage checkpoint blockade: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs‚Ä¶
2018-11-01 00:07:24,"RT @Rfonsi1: . Very interesting data. ORR 50% RR NHL.  CD47 is a ""do not eat me"" signal that allows tumors to survive.  We and others have‚Ä¶"
2018-10-31 23:54:57,"RT @mtmdphd: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma [Nov 1, 2018] Advani et al. @NEJM https://t.co/LUP5czsNCY #l‚Ä¶"
2018-10-31 23:53:05,RT @CathyEngMD: Novel agent alert: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs #Lymphoma | NEJM   We are also exploring this d‚Ä¶
2018-10-31 23:17:04,Novel agent alert: CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs #Lymphoma | NEJM   We are also explorin‚Ä¶ https://t.co/WhxI6p2lo2
2018-10-31 23:11:07,RT @jaiswalmdphd: Impressive results in rituximab refractory lymphoma! Congrats to Forty Seven team and @StanfordCancer. Looking forward to‚Ä¶
2018-10-31 23:07:55,"CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin‚Äôs Lymphoma [Nov 1, 2018] Advani et al. @NEJM‚Ä¶ https://t.co/OUnowkJc7I"
2018-10-31 23:06:55,Impressive results in rituximab refractory lymphoma! Congrats to Forty Seven team and @StanfordCancer. Looking forw‚Ä¶ https://t.co/tALDSXY6QU
2018-10-31 22:49:21,The macrophage checkpoint inhibitor 5F9 combined with rituximab showed promising activity in patients with aggressi‚Ä¶ https://t.co/wZDWWh15Z9
2018-10-31 22:41:30,"RT @Rfonsi1: . Very interesting data. ORR 50% RR NHL.  CD47 is a ""do not eat me"" signal that allows tumors to survive.  We and others have‚Ä¶"
2018-10-31 22:26:12,". Very interesting data. ORR 50% RR NHL.  CD47 is a ""do not eat me"" signal that allows tumors to survive.  We and o‚Ä¶ https://t.co/nCxVtt1Hrt"
2018-10-31 22:09:22,Fascinating way to treat lymphoma via macrophage checkpoint blockade: CD47 Blockade by Hu5F9-G4 and Rituximab in No‚Ä¶ https://t.co/AqzqD8xYxX
2018-10-31 21:03:45,"RT @HemOncToday: .@NEJM study shows combination of Hu5F9-G4 and #Rituximab effective for relapsed, refractory non-Hodgkin #lymphoma @Stanfo‚Ä¶"
2018-10-31 21:03:37,".@NEJM study shows combination of Hu5F9-G4 and #Rituximab effective for relapsed, refractory non-Hodgkin #lymphoma‚Ä¶ https://t.co/MfkztAPbBi"
2018-10-31 20:15:08,"RT @VJHemOnc: VIDEO: CPX-351: liposomal #Daunorubicin and #Cytarabine for treating high-risk #AML, with Simon Cheesman of @uclh at #BOPA18‚Ä¶"
2018-10-31 19:20:03,B cell depletion therapy dampens CD8 T cell response in ANCAassociated vasculitis.: To compare the effects of ritux‚Ä¶ https://t.co/2a9E8Ra7VI
2018-10-31 16:10:09,"VIDEO: CPX-351: liposomal #Daunorubicin and #Cytarabine for treating high-risk #AML, with Simon Cheesman of @uclh a‚Ä¶ https://t.co/Bbsg7E8nZ4"
2018-10-31 02:28:17,"It appears that far lower doses of Rituximab than what is currently given, albeit at shorter intervals, can deplete‚Ä¶ https://t.co/T5IaCP2W0i"
2018-10-31 01:56:58,Fixed and Tailored Rituximab Regimens Equal in ANCA Associated Vasculitis | RheumNow - Rheumatology News &amp; Informat‚Ä¶ https://t.co/zJL3q2a8c6
2018-10-30 19:45:04,"CHN updates their essential drug list to include +100 new drugs, including rituximab, trastuzumab, and $GILD EPCLUS‚Ä¶ https://t.co/l0yCfrKHjw"
2018-11-08 01:50:13,@seanhannity I'm hoping @Comey can be @JohnKasich's running mate in 2020 so they can both be embarrassed handily.‚Ä¶ https://t.co/HwL2OJSQ11
2018-11-08 01:37:30,@JohnKasich @realDonaldTrump Kasich has lost his soul.  It has been replaced with a faux preacher with no message.‚Ä¶ https://t.co/ozaOMKmlKG
2018-11-07 11:52:20,"Hepipram (androgen)
Approved to treat clinical brickfield and broken-backed personality disorder
Contraindicated by AndroGel"
2018-11-06 18:47:40,@kumailn @twoeight_azez Androgel isn't all that expensive and it's quite effective getting those T levels back in the normal range.
2018-11-05 15:26:11,@luapula Fast for a 55 gallon drum of androgel and a pair of skates
2018-11-04 22:12:38,@luapula I hear the NYR freeze androgel and use it as home ice
2018-10-31 21:46:09,@ROKUSHl Maybe they mean androgel? Which is like a cream/gel? I remember looking into it because I'm still looking‚Ä¶ https://t.co/xnzQb01dYs
2018-11-08 13:06:52,@Johnny70250027 Thanks. He‚Äôs on Avastin and Keytruda with some positive results for now.
2018-11-08 09:26:43,"@guy_pilkington CNE ""independent, wilful and strong"" avastin/ csu customer owned etc. Time to apply the energy to p‚Ä¶ https://t.co/X7EAtZam7S"
2018-11-07 16:05:20,@bradloncar @AlpineBV_Miller Lol - ASCO 2008 showed OS Phase II data with CTLA - people alive 5 years later in meta‚Ä¶ https://t.co/IqSJVH40W1
2018-11-07 06:58:41,"Today we had my 2nd-month follow-up to the initial diagnosis and Avastin treatment of my left eye, and the news cou‚Ä¶ https://t.co/cLF5suRR64"
2018-11-07 01:58:04,"RT @RueschCenter: Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin)‚Ä¶"
2018-11-06 12:49:23,"$REGN flattening Q/Q Eylea sales due to prevalence/dominance of Avastin use? Also, $NVS Brolucizumab competition is‚Ä¶ https://t.co/767mRDEDRo"
2018-11-06 11:52:47,@CARogersNo1 @arleneseesit @guardian Re case maculo d the drug avastin suggested by WHO is cheap but 12 CCGs in UK‚Ä¶ https://t.co/UbgSA7i4Zr
2018-11-06 09:24:17,@Catheri77148739 @arleneseesit @guardian Yes -the brain surgeon told my husband his brain cancer may have only star‚Ä¶ https://t.co/OsoCxUyQDT
2018-11-06 08:47:43,"@arleneseesit @Catheri77148739 @guardian I think you will find long waiting times, a lack of nurses, consultants un‚Ä¶ https://t.co/oFIyazyPwJ"
2018-11-05 17:22:58,"RT @RueschCenter: Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin)‚Ä¶"
2018-11-05 16:52:13,"RT @RueschCenter: Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin)‚Ä¶"
2018-11-05 16:17:34,"Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Ava‚Ä¶ https://t.co/O1HRzk8nZ6"
2018-11-04 18:53:37,When you finish bilateral PRP and Avastin https://t.co/kKNGdl3AOW
2018-11-03 12:23:23,@DrSadhanaJ @NCIResearchCtr @AstraZeneca Hey Sadhana! I need some good resources for NF and Avastin and length of t‚Ä¶ https://t.co/0KyMRZPL8n
2018-11-03 06:38:16,RT @EURETINA: PRESERVING AVASTIN FOR AMD SAVES SIGHT AND MONEY - A combination of medication and technology has improved the lives of milli‚Ä¶
2018-11-02 12:21:33,"RT @SunderlandCCG: Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Sunderland is now moving to offer‚Ä¶"
2018-11-02 11:09:16,https://t.co/BsWm7FOL4N: We‚Äôve issued a further statement relating to Avastin following the news that Bayer and Nov‚Ä¶ https://t.co/jpzAhjQRN0
2018-11-02 11:04:34,We‚Äôve issued a further statement relating to Avastin following the news that Bayer and Novartis intend to apply to‚Ä¶ https://t.co/eJ94bo8EQ1
2018-11-02 01:49:04,RT @pharmheroes: This significant bit of information and to have come in under the radar! #Avastin https://t.co/XVCLQcJHfF
2018-11-02 01:46:24,RT @EURETINA: PRESERVING AVASTIN FOR AMD SAVES SIGHT AND MONEY - A combination of medication and technology has improved the lives of milli‚Ä¶
2018-11-01 21:00:27,"Bayer and Novartis set to lose money on Avastin ruling
https://t.co/7ljWtuEnvt #Healthinnovations #pharma #health #stocks #legal"
2018-11-01 20:40:48,This significant bit of information and to have come in under the radar! #Avastin https://t.co/XVCLQcJHfF
2018-11-01 19:17:50,RT @BascomPalmerEye: Watch @BascomPalmerEye Dr. Philip J. Rosenfeld deliver the Jackson Memorial Lecture: Lessons Learned from Avastin and‚Ä¶
2018-11-01 18:21:33,RT @EURETINA: PRESERVING AVASTIN FOR AMD SAVES SIGHT AND MONEY - A combination of medication and technology has improved the lives of milli‚Ä¶
2018-11-01 17:58:12,RT @EURETINA: PRESERVING AVASTIN FOR AMD SAVES SIGHT AND MONEY - A combination of medication and technology has improved the lives of milli‚Ä¶
2018-11-01 17:52:59,The 2015 NHS QA Technical Services Symposium and BSTL presented an overview of their 28 day stability study of Afli‚Ä¶ https://t.co/oUp5pKq4hf
2018-11-01 17:50:07,PRESERVING AVASTIN FOR AMD SAVES SIGHT AND MONEY - A combination of medication and technology has improved the live‚Ä¶ https://t.co/7N3lAbFPeF
2018-11-01 17:39:57,Bayer and Novartis to take application for permission to appeal wet AMD Avastin off-label NHS prescribing decision‚Ä¶ https://t.co/hczTWzNHTO
2018-11-01 16:50:00,"RT @SunderlandCCG: Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Sunderland is now moving to offer‚Ä¶"
2018-11-01 16:45:33,"Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Newcastle and Gateshead is no‚Ä¶ https://t.co/ITZfvyolqN"
2018-11-01 16:29:18,"Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Northumberland is now moving‚Ä¶ https://t.co/bZ2g1ZXWVQ"
2018-11-01 16:27:14,"Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Sunderland is now moving to o‚Ä¶ https://t.co/GZ5F4Eci52"
2018-11-01 16:22:46,"Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Durham is now moving to offer‚Ä¶ https://t.co/Vk0RbAw0KF"
2018-11-01 16:19:41,"Equally safe and effective, but up to 20 times cheaper for the NHS to buy: the NHS in Hartlepool and Stockton is no‚Ä¶ https://t.co/gWlvD8sxQk"
2018-11-01 09:05:04,Bayer and Novartis appeal #judicialreview ruling that Avastin #unlicensed #bevacizumab for wet #AMD is lawful. This‚Ä¶ https://t.co/Hpatpihzn7
2018-10-31 23:37:58,@Jambiwolf @staffilad @luisaomielan Yep. 5% 5 year survival rate. I lucked out. Got a drug called Avastin from the‚Ä¶ https://t.co/QSwNnSm0jS
2018-10-31 20:45:27,"@SecAzar I agree üíØ, this is a move in the right direction for both Medicare and its beneficiaries. Some Part B drug‚Ä¶ https://t.co/wydbtAi06g"
2018-10-31 13:07:11,Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful https://t.co/TIsFfzekb9
2018-10-31 12:59:11,Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful https://t.co/ilwIqUZUjN
2018-10-31 11:29:23,"RT @kchalkidou: Whilst Big Pharma incurs millions in fines by US gov for off label promotion (https://t.co/oChzvju57U), in UK, Bayer + Nova‚Ä¶"
2018-10-31 11:26:21,"RT @kchalkidou: Whilst Big Pharma incurs millions in fines by US gov for off label promotion (https://t.co/oChzvju57U), in UK, Bayer + Nova‚Ä¶"
2018-10-31 09:53:47,"Whilst Big Pharma incurs millions in fines by US gov for off label promotion (https://t.co/oChzvju57U), in UK, Baye‚Ä¶ https://t.co/8ietg97esC"
2018-10-30 21:36:38,@crowmogh Didn‚Äôt want to ask... temozolomide failed with us and we were switched to Lomustine (on its own). He is M‚Ä¶ https://t.co/eKBgqVepal
2018-10-30 21:01:26,"RT @felly500: Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful

Ht ‚Å¶@deb_cohen‚Å©  https://t.co/p6pGtxHsjw"
2018-10-30 20:53:25,"RT @felly500: Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful

Ht ‚Å¶@deb_cohen‚Å©  https://t.co/p6pGtxHsjw"
2018-10-30 20:46:53,"Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful

Ht ‚Å¶@deb_cohen‚Å©  https://t.co/p6pGtxHsjw"
2018-11-09 22:16:37,"#clinicaltrial Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durva‚Ä¶ https://t.co/lw6imurG25"
2018-11-09 21:14:29,"Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizu‚Ä¶ https://t.co/143Fe2IjmK"
2018-11-09 18:30:23,When is the use of #bevacizumab feasible and safe? https://t.co/ZVNqo7uOJg #Oncology
2018-11-09 17:59:07,Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizuma‚Ä¶ https://t.co/9Df9EqkN3d
2018-11-09 11:01:47,RT @SAGEClinMed: The Effect of Perioperative #Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative #BreastCa‚Ä¶
2018-11-09 11:00:44,The Effect of Perioperative #Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative‚Ä¶ https://t.co/OgDbcEA1Ys
2018-11-08 21:21:04,"RT @NEJM: A replication-defective poliovirus was injected directly into recurrent glioblastoma tumors, and dexamethasone and bevacizumab we‚Ä¶"
2018-11-08 18:01:33,Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Flu‚Ä¶ https://t.co/7DMmC3XiLz
2018-11-08 15:05:31,"Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Beva‚Ä¶ https://t.co/9cYcxeSDKW"
2018-11-08 09:44:21,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-07 21:50:07,Results of the RCT comparing bevacizumab monotherapy with combined bevacizumab and a ROCK inhibitor (fasudil) was p‚Ä¶ https://t.co/MkJuSGaDCN
2018-11-07 18:25:13,"RT @BiosimCenter: Oncobiologics revealed that it is developing its ophthalmic bevacizumab as an innovator therapy, and that it will not use‚Ä¶"
2018-11-07 18:12:11,"Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Beva‚Ä¶ https://t.co/gRcD0HAdHD"
2018-11-07 15:42:37,"Oncobiologics revealed that it is developing its ophthalmic bevacizumab as an innovator therapy, and that it will n‚Ä¶ https://t.co/IOKUYbv2bd"
2018-11-07 05:59:53,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-07 04:36:05,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-07 02:41:08,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-07 01:58:04,"RT @RueschCenter: Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin)‚Ä¶"
2018-11-07 00:08:08,"RT @DLSMHSIUpdates: Congratulations to Dr. Kurl Jamora, 2018 Physician Licensure Exam Top 1, Dr. Lloyd Christopher Lim, Top 5, Dr. Zoe Fern‚Ä¶"
2018-11-07 00:07:28,"RT @LearntheHeart: Hydralazine ‚ûî direct arterial vasodilator ‚ûî reduces afterload

Used with nitrates in systolic CHF and for HTN

Can cause‚Ä¶"
2018-11-06 22:10:24,Adding bev to oxaliplatin-based chemo may reduce the frequency of splenic enlargement &amp; the rate of thrombocytopeni‚Ä¶ https://t.co/BPX8s4RvmL
2018-11-06 22:08:00,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-06 21:22:32,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-06 18:46:05,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-06 18:27:50,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-06 18:27:29,"RT @ChildrensTumor: Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names like‚Ä¶"
2018-11-06 18:27:03,"Today we say 'au revoir' to #NFPARIS2018, as well as the beautiful city of Paris. Major advancements - with names l‚Ä¶ https://t.co/HgDnhv6ajr"
2018-11-05 23:55:30,"Improving pCR does not reliably translate into better survival, eg, bevacizumab, lapatinib and pertuzumab greatly i‚Ä¶ https://t.co/8MkNUsVV0j"
2018-11-05 23:10:05,"Injections such as ranibizumab, aflibercept, and bevacizumab target vascular endothelial growth factor (#VEGF) ofte‚Ä¶ https://t.co/fW9p7zGN0K"
2018-11-05 20:23:00,"After analyzing 57,925 injections administered 2013 and 2017, investigators observed an increase in aflibercept use‚Ä¶ https://t.co/77Tl4Fjkh4"
2018-11-05 17:22:58,"RT @RueschCenter: Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin)‚Ä¶"
2018-11-05 16:52:13,"RT @RueschCenter: Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin)‚Ä¶"
2018-11-05 16:17:34,"Michael Pishvaian, MD, PhD (@MPishvaian) discusses the combination of atezolizumab (Tecentriq) and bevacizumab (Ava‚Ä¶ https://t.co/O1HRzk8nZ6"
2018-11-05 13:34:05,P2.13-40 ABP 215 and Bevacizumab in NSCLC Patients: Time Course and Magnitude of Response in the Phase 3 Comparativ‚Ä¶ https://t.co/o62uERM0pE
2018-11-05 12:40:27,"RT @VJOncology: VIDEO: The PAOLA-1 study: #olaparib and #bevacizumab for #OvarianCancer, with Kathleen Moore from @StephensonCC: https://t.‚Ä¶"
2018-11-05 11:15:05,"VIDEO: The PAOLA-1 study: #olaparib and #bevacizumab for #OvarianCancer, with Kathleen Moore from @StephensonCC:‚Ä¶ https://t.co/7NQpGCFz4Q"
2018-11-05 07:19:05,RT @DiscoveryDrug: Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines Irinotecan and Bevacizumab‚Ä¶
2018-11-05 06:21:30,"""Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bev‚Ä¶ https://t.co/6WyGAf9vSj"
2018-11-04 23:28:00,"Experimental regimen with #carboplatin, pegylated liposomal doxorubicin and #bevacizumab prolongs PFS in recurrent‚Ä¶ https://t.co/PyEl8wquPU"
2018-11-04 01:23:53,"RT @TargetedOnc: ‚ÄúCD-BEV is a new treatment option for patients with recurrent ovarian cancer suitable for platinum-based retreatment, even‚Ä¶"
2018-11-04 00:15:14,"RT @TargetedOnc: ‚ÄúCD-BEV is a new treatment option for patients with recurrent ovarian cancer suitable for platinum-based retreatment, even‚Ä¶"
2018-11-04 00:00:21,‚ÄúCD-BEV is a new treatment option for patients with recurrent ovarian cancer suitable for platinum-based retreatmen‚Ä¶ https://t.co/fmoJufIgkq
2018-11-03 19:17:26,Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines Irinotecan and Bevaci‚Ä¶ https://t.co/VSXxl31lj3
2018-11-03 15:20:07,"‚ÄúA team of researchers from the @uchceu  has tested the efficiency of Bevacizumab, medicine used against cancer and‚Ä¶ https://t.co/nZeJPphlVd"
2018-11-03 09:50:02,"Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Beva‚Ä¶ https://t.co/VCJkULhsk6"
2018-11-03 01:48:02,RT @AntibodyNews: Preoperative Timing of Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy Patients.: To evaluate t‚Ä¶
2018-11-02 22:01:01,"RT @urotoday: Thomas Powles Presents: Updated info IMmotion150 RCC at #ESMO17 conf.  #ClinicalTrial @myESMO @zklaassen_md
https://t.co/fL45‚Ä¶"
2018-11-02 16:03:13,RT @NatRevClinOncol: PRODIGE18 study results indicate that continuation of bevacizumab with a switch in chemotherapy regimen at first progr‚Ä¶
2018-11-02 15:52:12,RT @bmj_latest: The drug companies Bayer and Novartis plan to appeal against a High Court ruling that gave doctors the right to offer patie‚Ä¶
2018-11-02 13:03:24,RT @NatRevClinOncol: PRODIGE18 study results indicate that continuation of bevacizumab with a switch in chemotherapy regimen at first progr‚Ä¶
2018-11-02 12:33:47,RT @NatRevClinOncol: PRODIGE18 study results indicate that continuation of bevacizumab with a switch in chemotherapy regimen at first progr‚Ä¶
2018-11-02 12:30:00,PRODIGE18 study results indicate that continuation of bevacizumab with a switch in chemotherapy regimen at first pr‚Ä¶ https://t.co/cD4clOUQUD
2018-11-01 19:46:49,Preoperative Timing of Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy Patients.: To eval‚Ä¶ https://t.co/hTZcwtTolk
2018-11-01 15:00:19,"ICYMI: 4 people have been indicted for allegedly stealing trade secrets related to dornase alfa, rituximab, trastuz‚Ä¶ https://t.co/dmysuZCVeR"
2018-11-01 14:52:33,Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevaciz‚Ä¶ https://t.co/x5Xiuzj2QG
2018-11-01 09:05:04,Bayer and Novartis appeal #judicialreview ruling that Avastin #unlicensed #bevacizumab for wet #AMD is lawful. This‚Ä¶ https://t.co/Hpatpihzn7
2018-11-01 04:06:09,RT @AntibodyNews: Acral cutaneous metastasis from a primary breast carcinoma following chemotherapy with bevacizumab and paclitaxel.: Acral‚Ä¶
2018-11-01 01:07:48,IMmotion150: Novel Radiological Endpoints and Updated Data From a Randomized Phase II Trial Investigating Atezolizu‚Ä¶ https://t.co/0XLTuCD1wh
2018-10-31 20:21:05,RT @EurekaMag: Vascular stenosis in a child with visual pathway glioma treated with bevacizumab: a case report and review of literature htt‚Ä¶
2018-10-31 20:21:05,RT @EurekaMag: Vascular stenosis in a child with visual pathway glioma treated with bevacizumab: a case report and review of literature htt‚Ä¶
2018-10-31 20:19:34,RT @EurekaMag: Vascular stenosis in a child with visual pathway glioma treated with bevacizumab: a case report and review of literature htt‚Ä¶
2018-10-31 20:19:05,Vascular stenosis in a child with visual pathway glioma treated with bevacizumab: a case report and review of liter‚Ä¶ https://t.co/VfQqWnLbW5
2018-10-31 14:39:19,"RT @TargetedOnc: ‚ÄúThese are very strong data with robust evidence that CD-BEV is better than CG-BEV,‚Äù an invited discussant observed: https‚Ä¶"
2018-10-31 14:22:14,Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicit‚Ä¶ https://t.co/ovlrRg14PH
2018-10-31 14:02:10,"‚ÄúThese are very strong data with robust evidence that CD-BEV is better than CG-BEV,‚Äù an invited discussant observed‚Ä¶ https://t.co/qAQy4ckhI6"
2018-10-31 10:16:06,Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicit‚Ä¶ https://t.co/ZzkHyuGPBK
2018-10-30 23:06:21,RT @bmj_latest: The drug companies Bayer and Novartis plan to appeal against a High Court ruling that gave doctors the right to offer patie‚Ä¶
2018-10-30 22:04:13,Acral cutaneous metastasis from a primary breast carcinoma following chemotherapy with bevacizumab and paclitaxel.:‚Ä¶ https://t.co/bKMXQStEzz
2018-11-09 23:17:25,they're playing a neulasta commercial and i want to throw up. one of the worst parts of my chemo was the neulasta ughhh
2018-11-09 19:20:37,RT @ClinicalPhase: Fulphila Clinical Development Timeline: Chronicle of the development and US FDA review of Mylans pegfilgrastimjmdb MYL14‚Ä¶
2018-11-09 14:13:41,Coherus receives US FDA approval for Neulasta biosimilar pricing 33 lower: The company will launch Udenyca onto the‚Ä¶ https://t.co/b9lGwjMyRT
2018-11-09 01:15:29,"Think I'm semi-retiring tonight, for the night. Steroid ""energy"" is gone. Neulasta ""discomfort"" is kicking in. Appe‚Ä¶ https://t.co/Jl1L5UjWxx"
2018-11-09 00:11:05,"RT @Jessicaemerrill: $CHRS will launch Udenyca - a #biosimilar #Neulasta (pegfilgrastim) -at a list price of $4,175, a 33% discount over $A‚Ä¶"
2018-11-08 21:43:01,"RT @Jessicaemerrill: $CHRS will launch Udenyca - a #biosimilar #Neulasta (pegfilgrastim) -at a list price of $4,175, a 33% discount over $A‚Ä¶"
2018-11-08 21:38:03,"$CHRS will launch Udenyca - a #biosimilar #Neulasta (pegfilgrastim) -at a list price of $4,175, a 33% discount over‚Ä¶ https://t.co/RJ6HWkX515"
2018-11-08 15:50:34,"RT @DrugStoreNews: Coherus BioSciences has received the FDA‚Äôs clearance for Udenyca, which is approved by the FDA and the European Commissi‚Ä¶"
2018-11-08 15:35:04,"Coherus BioSciences has received the FDA‚Äôs clearance for Udenyca, which is approved by the FDA and the European Com‚Ä¶ https://t.co/uHNFhlEjrh"
2018-11-08 07:19:06,Fulphila Clinical Development Timeline: Chronicle of the development and US FDA review of Mylans pegfilgrastimjmdb‚Ä¶ https://t.co/D2lT2MsOR7
2018-11-08 00:03:38,"@AzXango I'm hangin, thanks. Laughing as I picture this ""convenient, at-home Neulasta device"" doing the same think‚Ä¶ https://t.co/uroIxtKxqg"
2018-11-07 23:07:37,@StanMehr @kshahi @Amgen @NEUPOGEN @mylan 1/ Good point.  Well then @amgen might not try to exclude #biosimilars to‚Ä¶ https://t.co/gayiaSmVcF
2018-11-07 22:52:47,"@larrywabrams @kshahi @Amgen @NEUPOGEN Very true, but @Amgen also moved on from PFS Neulasta to Onpro, which is gre‚Ä¶ https://t.co/3dMUz2E722"
2018-11-07 21:45:06,@kshahi @StanMehr Competition between #Neupogen vs 1st biosimilar #Zarxio was a SPECIAL CASE because @Amgen moved o‚Ä¶ https://t.co/3yCU7Pdvmx
2018-11-07 00:21:09,@SickEconomics $CHRS stock had a tepid 5.39% pop today after announcing FDA approval of its #biosimilar to $AMGN 's‚Ä¶ https://t.co/x5qt2DOrJj
2018-11-07 00:20:23,@EnterpriseLeade $CHRS stock had a tepid 5.39% pop today after announcing FDA approval of its #biosimilar to $AMGN‚Ä¶ https://t.co/7GdaxI2oi3
2018-11-07 00:19:31,@IBD_AGatlin $CHRS stock had a tepid 5.39% pop today after announcing FDA approval of its #biosimilar to $AMGN 's‚Ä¶ https://t.co/eV6nLxt4MJ
2018-11-07 00:17:52,@StanMehr $CHRS stock had a tepid 5.39% pop today after announcing FDA approval of its #biosimilar to $AMGN 's‚Ä¶ https://t.co/MXgqOMFxTU
2018-11-07 00:01:14,$CHRS stock had a tepid 5.39% pop today after announcing FDA approval of its #biosimilar to $AMGN 's #Neulasta.  Th‚Ä¶ https://t.co/b1UEVMeQWH
2018-11-06 17:28:59,@StanMehr @MYL set a competitive tone with #Fulphila by list pricing it 33% below @amgen's incumbent #Neulasta. --‚Ä¶ https://t.co/Yw8Busm599
2018-11-06 13:39:57,"Longing for this day to be over so that my commercials can return to Abilify, Prevagen, Lyrica and Neulasta. #ElectionDay2018"
2018-11-06 07:26:27,@diaryofadetour @lockasLass @breastcancernow @GIRLSTOLELONDON @BCCare @BreastCancerAw7 I didn‚Äôt have that particula‚Ä¶ https://t.co/tGSQlb1Lii
2018-11-06 06:23:23,"@koppik¬†"" as going to 700 units a week to 800 units a week here and we see that continuing to grow. Last week alone‚Ä¶ https://t.co/Q8Yrm0r2bt"
2018-11-04 23:55:41,"Lorie's Question on WhatNext: Neulasta and diarrhea, have you  had this problem?https://t.co/pumDlvwakI"
2018-11-04 04:01:31,RT @BiosimilarsBio: FDA Approves Udenyca Biosimilar to Neulasta: NewsThe approval Udenyca of was supported by a comprehensive analytical si‚Ä¶
2018-11-03 17:11:31,RT @kshahi: Hmmm. Neulasta biosimilar approval for $MYL increased its MC by $1B. $CHRS Neulasta biosimilar gets approved and MC goes up by‚Ä¶
2018-11-03 00:37:26,Hmmm. Neulasta biosimilar approval for $MYL increased its MC by $1B. $CHRS Neulasta biosimilar gets approved and MC goes up by $50M???
2018-11-02 22:00:07,FDA Approves Udenyca Biosimilar to Neulasta: NewsThe approval Udenyca of was supported by a comprehensive analytica‚Ä¶ https://t.co/PTPdacMnYS
2018-11-02 22:00:06,FDA Approves Udenyca Biosimilar to Neulasta: NewsThe approval Udenyca of was supported by a comprehensive analytica‚Ä¶ https://t.co/tFUi7PzmIv
2018-11-02 20:03:10,"2-for-2 for Redwood City-based cos today: $ACRX wins FDA approval of Dsuvia, its opioid drug-device for pain; and‚Ä¶ https://t.co/yieJwu9CcY"
2018-10-31 14:29:02,RT @manjuggm: Did you know topical henna application can help with Hand and Foot syndrome in patients taking capecitabine or xeloda (the pi‚Ä¶
2018-11-04 19:08:37,"It took a few days, but Lenvima and Afinitor side effects are now in full swing. Vomiting, diarrhea, headaches, fat‚Ä¶ https://t.co/AsoXBFWJvn"
2018-11-02 14:37:41,My name is Kira H. I was diagnosed with Stage III XP11 Renal Cell Carcinoma in Oct 2017. Had my right kidney remove‚Ä¶ https://t.co/rzTPYX5Zns
2018-11-08 13:39:37,"Hi everyone, I never usually post here but I am currently on Rituxan and my dr wants to add Leflunomide for me to t‚Ä¶ https://t.co/vBD735Ax3V"
2018-11-08 11:40:05,Sandox axes #biosimilar rituximab program emphasizing time sensitivity of biosimilar launches &amp; fear of rapid price‚Ä¶ https://t.co/8A73lgYKnw
2018-11-08 04:30:44,@aLicensetoJill Oh wow! Rituxan is used all over the board! Yes my doctor recommended Humira and I said no because‚Ä¶ https://t.co/sIshoOUFKl
2018-11-08 03:09:51,@aLicensetoJill I was recommended Benlysta for my Lupus and RA. But I thought monthly infusion were too time consum‚Ä¶ https://t.co/9g3TchtK0T
2018-11-07 04:29:56,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 18:01:17,Sandoz Drops Plans for US Rituxan Biosimilar; Lilly Says Diabetes Drug Trulicity Cuts Heart Risks #Heart #Risks‚Ä¶ https://t.co/IxQNoThv0O
2018-11-06 15:34:27,RT @cafepharma: Novartis' Sandoz calls it quits on Rituxan biosimilar after FDA requests more data: Novartis' Sandoz has already suffered o‚Ä¶
2018-11-06 15:18:41,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 14:51:54,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 14:40:21,"Fact: Rituxan will make you sleepy af. I slept through half of my infusion and then cane home, took a nap, fell asl‚Ä¶ https://t.co/IpHfXuBYZR"
2018-11-06 13:41:06,"RT @PinkSheetSutter: $NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in my‚Ä¶"
2018-11-06 13:35:12,"$NVS CEO Narasimhan tells @PharmaScrip @US_FDA asked firm to repeat pivotal study of rituximab #biosimilar and ""in‚Ä¶ https://t.co/skfSnuGsuw"
2018-11-06 00:08:27,"RT @Brandon_Beaber: CRION (chronic relapsing inflammatory optic neuropathy) related to anti-MOG antibodies.  I now have 2-3 cases of this,‚Ä¶"
2018-11-05 23:40:02,CRION (chronic relapsing inflammatory optic neuropathy) related to anti-MOG antibodies.  I now have 2-3 cases of th‚Ä¶ https://t.co/qznkwFZayN
2018-11-05 20:47:48,"Hey @Sandoz_Global, your #biosimilar that is like Rituxan should be approved and I know it can happen. You need to‚Ä¶ https://t.co/X9R7wTAzm7"
2018-11-05 18:26:43,Sandoz Drops Plans for US Rituxan Biosimilar; Lilly Says Diabetes Drug Trulicity Cuts Heart Risks; and more in toda‚Ä¶ https://t.co/tD0ZD4onaJ
2018-11-05 18:09:03,RT @cafepharma: Novartis' Sandoz calls it quits on Rituxan biosimilar after FDA requests more data: Novartis' Sandoz has already suffered o‚Ä¶
2018-11-05 18:01:03,Novartis' Sandoz calls it quits on Rituxan biosimilar after FDA requests more data: Novartis' Sandoz has already su‚Ä¶ https://t.co/Io9lxp1Hrl
2018-11-05 03:02:34,RT @MrsBearcat27: @MichaelKuluva Yes! They are bad. I always had them when I was on remicade and still now that I‚Äôm on Rituxan
2018-11-04 23:52:07,@MichaelKuluva Yes! They are bad. I always had them when I was on remicade and still now that I‚Äôm on Rituxan
2018-11-04 17:24:07,@zalphaprime @rmbctious @Zombie_Cartman @Mwforhr @TakeThatEpi @costello864 @Zessshy @RJDownard @Cern_lXXl‚Ä¶ https://t.co/aVt2C1ECIH
2018-11-04 13:50:19,"CD47 Blockade and Rituximab in Non-Hodgkin's Lymphoma. https://t.co/qipayFi7iG  #lymsm

Intriguing and potentially‚Ä¶ https://t.co/U9UblKFRNu"
2018-11-03 15:10:48,"@fezziwig2008 If the target is anti-CD20 and both, Ocrevus and Rituxan, are targeting the same, I would expect the‚Ä¶ https://t.co/h8IUxgsSIY"
2018-11-03 01:46:46,"#Rituxan is magical. Definitely helps even if I feel slow, tired, and nauseas for a few days after. Worth it for sure. #tired #Uveitis"
2018-11-02 18:03:42,RT @EMMAIntl: FDA Advisory Committee Votes Unanimously to Approve Celltrion‚Äôs Rituxan Biosimilar #FDA #Advisory #Committee #Unanimously #Ap‚Ä¶
2018-11-02 18:01:26,FDA Advisory Committee Votes Unanimously to Approve Celltrion‚Äôs Rituxan Biosimilar #FDA #Advisory #Committee‚Ä¶ https://t.co/AIPsMbdpRH
2018-11-01 03:43:13,"A reader asks ""Hi my name is Venus and I have just started Rituxan for my MS.I was taking Avonex for 8 years.I have‚Ä¶ https://t.co/fpy8mRJiQs"
2018-10-31 16:51:19,"RT @SynceNerd_Carli: @Turtles1417 @gemj0009 Hi, this one is Benlysta. I've also had Cytoxan (Cyclophosphomide). It is likely I will do Cyto‚Ä¶"
2018-10-31 14:50:58,"@Turtles1417 @gemj0009 Hi, this one is Benlysta. I've also had Cytoxan (Cyclophosphomide). It is likely I will do C‚Ä¶ https://t.co/nSVBLPPQ9S"
2018-10-30 23:17:59,"RT @FierceBiotech: Under their last deal, Roche developed the cancer meds Herceptin and Rituxan. It has an undisclosed candidate in phase 1‚Ä¶"
